The Cu-Shield digital lock range was developed with assistance from Andrew Cross of ACT Surfaces Ltd, a consultant in the niche subject of antimicrobial materials. Andrew comments on how the 2020 Coronavirus outbreak has made everyone focus on items they touch and how infection spreads. Especially now as the combination of COVID-19 and winter pressures is an alarming double-blow for healthcare and for the economy, calling for additional preventative measures.
Research published in March 2020 in New England Journal of Medicine,  prompted the question: “Why does SARS-CoV-2 remain viable for such a short time on copper (only up to 4 hours) yet far longer (up to 72 hours) on plastic and stainless steel?“
Previous research  reported that Coronavirus (229E) remained viable for under an hour on copper, but for “several days” on other surfaces.
Work is ongoing by OECD  and ISO to standardise test protocols. The ISO stated: “Biocidal surfaces are a valuable tool because they destroy or inactivate unwanted pathogens, thus contributing to a cleaner environment. However, the performance of such surfaces can vary, giving rise to the need for effective guidelines and test methods to ensure they are up to scratch.” 
The ISO recently created an expert committee ISO/TC 330  to develop internationally-agreed test methods and guidance for assessment of any surfaces with antimicrobial activities, also their compatibility with different disinfectants and cleaning agents.
At ACT Surfaces Ltd, we welcome these developments and look forward to much-needed clarity enabling accurate comparison of antimicrobial materials: the robust body of evidence for copper  means you can be confident it actually works in real life.
 van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382:1564-7.
 Michels HT, Noyce JO, Keevil CW. Effects of temperature and humidity on the efficacy of methicillin-resistant Staphylococcus aureus challenged antimicrobial materials containing silver and copper. Lett Appl Microbiol. 2009 Aug;49(2):191-5. doi: 10.1111/j.1472-765X.2009.02637 .x. Epub 2009 Apr 25. PMID: 19413757; PMCID: PMC2779462.
 Dauvergne, E.; Lacquemant, C.; Adjidé, C.; Mullié, C. Validation of a Worst-Case Scenario Method Adapted to the Healthcare Environment for Testing the Antibacterial Effect of Brass Surfaces and Implementation on Hospital Antibiotic-Resistant Strains. Antibiotics 2020, 9, 245. https://doi.org/10.3390/antibiotics9050245
 Introductory overview: Michels HT, Keevil CW, Salgado CD, Schmidt MG. From Laboratory Research to a Clinical Trial: Copper Alloy Surfaces Kill Bacteria and Reduce Hospital-Acquired Infections. HERD. 2015 Fall;9(1):64-79. doi: 10.1177/1937586715592650. Epub 2015 Jul 10. PMID: 26163568; PMCID: PMC4561453.
If you have any questions or would simply like to discuss a new project, feel free to get in touch by clicking below.
Alternatively, you can call us on +44 (0) 1708 225700.
Our office address is: Unit 9 Upminster Trading Park, Warley Street, Upminster. RM14 3PJ